SEC Form 4 · accession 0001209191-18-061841

AVEO PHARMACEUTICALS INC · AVEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Scott D Sandell

10% Owner

Period of report

Dec 6, 2018

Accepted (ET)

Dec 10, 2018 · 5:23 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001325879

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Dec 6, 2018	P	27,300	$1.9932	A	20,191,738	I	See Note 2
Common Stock^F3,F2	Dec 7, 2018	P	117,100	$1.9843	A	20,308,838	I	See Note 2
Common Stock^F4,F2	Dec 10, 2018	P	26,000	$1.9837	A	20,334,838	I	See Note 2

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.97 to $2.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2The Reporting Person is a manager of NEA 15 GP, LLC, ("NEA 15 GP") which is the sole general partner of NEA Partners 15, L.P. ("NEA Partners 15"). NEA Partners 15 is the sole general partner of New Enterprise Associates 15, L. P. ("NEA 15"). NEA 15 is the sole member of Growth Equity Opportunities Fund IV, LLC ("GEO IV"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by GEO IV in which the Reporting Person has no pecuniary interest.
F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.955 to $2.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.96 to $2.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4.